Cart
sales@molnova.com
CCT077791
CAS No. 748777-47-1
CCT077791( —— )
Catalog No. M34060 CAS No. 748777-47-1
CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCCT077791
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
-
DescriptionCCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain | Histone Acetyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number748777-47-1
-
Formula Weight256.67
-
Molecular FormulaC9H5ClN2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(SC(Cl)=C1)C2=CC=C(N(=O)=O)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GSK046
GSK046 is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins(IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively).
-
BRD4-IN-4
BRD4-IN-4 is a selective BRD4 inhibitor with an IC50 value of 6.83 μM for BRD4.BRD4-IN-4 selectively inhibits the proliferation of the MV4-11 cell line and arrests the cells in G1 phase.BRD4-IN-4 can be used to study MLL leukemias.
-
CPI-203
CPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
